Leads To Development (L2D) is a privately owned company that was formed in 2009 to create a high value service company that provides support for clients developing innovative drugs. We have now grown to an international team of drug development experts. Working from our offices in Paris, France, we provide hands-on scientific and regulatory expertise in all aspects of non-clinical drug development. Our services span all stages of the drug development process, but are often focussed on the earlier stages: from the discovery of a candidate new drug up to and including the first tests in humans.
The expertise that we have built over the last ten years allows our clients to increase the chance of the successfully developing their promising new drugs, whilst reducing the time taken to initiate the clinical studies.